Characterizing the outcomes of metastatic papillary renal cell carcinoma

John Connor Wells, Frede Donskov, Anna P. Fraccon, Felice Pasini, Georg A. Bjarnason, Benoit Beuselinck, Jennifer J. Knox, Sun Young Rha, Neeraj Agarwal, Isaac Alex Bowman, Jae Lyun Lee, Sumanta K. Pal, Sandy Srinivas, Douglas Scott Ernst, Ulka N. Vaishampayan, Lori A. Wood, Robin Simpson, Guillermo De Velasco, Toni K. Choueiri, Daniel Y.C. Heng

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)


Outcomes of metastatic papillary renal cell carcinoma (pRCC) patients are poorly characterized in the era of targeted therapy. A total of 5474 patients with metastatic renal cell carcinoma (mRCC) in the International mRCC Database Consortium (IMDC) were retrospectively analyzed. Outcomes were compared between clear cell (ccRCC; n = 5008) and papillary patients (n = 466), and recorded type I and type II papillary patients (n = 30 and n = 165, respectively). Overall survival (OS), progression-free survival (PFS), and overall response rate (ORR) favored ccRCC over pRCC. OS was 8 months longer in ccRCC patients and the hazard ratio of death was 0.71 for ccRCC patients. No differences in PFS or ORR were detected between type I and II PRCC in this limited dataset. The median OS for type I pRCC was 20.0 months while the median OS for type II was 12.6 months (P = 0.096). The IMDC prognostic model was able to stratify pRCC patients into favorable risk (OS = 34.1 months), intermediate risk (OS = 17.0 months), and poor-risk groups (OS = 6.0 months). pRCC patient outcomes were inferior to ccRCC, even after controlling for IMDC prognostic factors. The IMDC prognostic model was able to effectively stratify pRCC patients.

Original languageEnglish
Pages (from-to)902-909
Number of pages8
JournalCancer medicine
Issue number5
Publication statusPublished - 2017 May

Bibliographical note

Publisher Copyright:
© 2017 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research


Dive into the research topics of 'Characterizing the outcomes of metastatic papillary renal cell carcinoma'. Together they form a unique fingerprint.

Cite this